flomoxef has been researched along with Cronobacter Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Cao, B; Cheng, J; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Xu, Z; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Ichiyama, S; Matsumura, Y; Nagao, M; Takakura, S; Tanaka, M; Yamamoto, M | 1 |
Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T | 1 |
4 other study(ies) available for flomoxef and Cronobacter Infections
Article | Year |
---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proteus mirabilis; Sequence Analysis, DNA | 2015 |
In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefmetazole; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
Topics: Abdomen; Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefotiam; Cefozopran; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laparotomy; Microbial Sensitivity Tests; Monte Carlo Method; Postoperative Complications; Surgical Wound Infection | 2008 |